1
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- BTIG analyst Julian Harrison upgraded the rating for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) from Neutral to Buy and announced a price target of $8. Aclaris Therapeutics shares closed at $3.14 on Monday. See how other analysts view this stock.
- HSBC analyst Wesley Brooks upgraded the rating for QuantumScape Corporation (NYSE:QS) from Reduce to Hold and announced a price target of $5.3. QuantumScape shares closed at $4.73 on Monday. See …
Full story available on Benzinga.com
Visited 1 times, 1 visit(s) today